Protalix BioTherapeutics (PLX) Return on Capital Employed Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 4,930.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,930.00 |
| Dec 31, 2025 | 1,058.00 |
| Sep 30, 2025 | 7,747.00 |
| Jun 30, 2025 | 6,045.00 |
| Mar 31, 2025 | 6,156.00 |
| Dec 31, 2024 | 5,443.00 |
| Sep 30, 2024 | 543.00 |
| Jun 30, 2024 | 9,115.00 |
| Mar 31, 2024 | 15,131.00 |
| Dec 31, 2023 | 4,242.00 |
| Sep 30, 2023 | 4,544.00 |
| Jun 30, 2023 | 3,216.00 |
| Mar 31, 2023 | -921.00 |
| Dec 31, 2022 | 10,150.00 |
| Sep 30, 2022 | 1,180.00 |
| Jun 30, 2022 | 1,377.00 |
| Mar 31, 2022 | 565.00 |
| Dec 31, 2021 | 562.00 |
| Sep 30, 2021 | 5,086.00 |
| Jun 30, 2021 | -6,282.00 |
| Mar 31, 2021 | -5,126.00 |
| Dec 31, 2020 | 6,208.00 |
| Sep 30, 2020 | 10,802.00 |
| Jun 30, 2020 | 7,918.00 |
| Mar 31, 2020 | 5,282.00 |
| Dec 31, 2019 | 21,259.00 |
| Sep 30, 2019 | -2,841.00 |
| Jun 30, 2019 | -1,585.00 |
| Mar 31, 2019 | -2,632.00 |
| Mar 31, 2017 | -1,154.00 |
| Dec 31, 2016 | -28,916.00 |
| Sep 30, 2016 | -916.00 |
| Jun 30, 2016 | 2,591.00 |
| Mar 31, 2016 | -1,040.00 |